129 related articles for article (PubMed ID: 30562566)
1. Initiation of methotrexate with or without a test dose: A retrospective toxicity study.
Herrmann T; Buhnerkempe M; Wilson ML
J Am Acad Dermatol; 2019 Apr; 80(4):1160-1162. PubMed ID: 30562566
[No Abstract] [Full Text] [Related]
2. Severe complications after high-dose methotrexate treatment.
Takami M; Kuniyoshi Y; Oomukai T; Ishida T; Yamano Y
Acta Oncol; 1995; 34(5):611-2. PubMed ID: 7546826
[No Abstract] [Full Text] [Related]
3. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
Wiczer T; Dotson E; Tuten A; Phillips G; Maddocks K
J Oncol Pharm Pract; 2016 Jun; 22(3):430-6. PubMed ID: 26152702
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.
Bruijn MS; Horváth B; van Voorst Vader PC; Willemze R; Vermeer MH
Br J Dermatol; 2015 Nov; 173(5):1319-22. PubMed ID: 25998985
[No Abstract] [Full Text] [Related]
5. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia.
Diaz J; Thomas MB; Paz-Pabon C; Hernandez E
J Reprod Med; 2012; 57(9-10):411-4. PubMed ID: 23091988
[TBL] [Abstract][Full Text] [Related]
7. Acute methotrexate toxicity presenting with bullous lesions: an unusual presentation.
Sanke S; Yadav P; Chander R; Chandra J
Eur J Clin Pharmacol; 2017 Apr; 73(4):515-516. PubMed ID: 27975132
[No Abstract] [Full Text] [Related]
8. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
[No Abstract] [Full Text] [Related]
9. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
Tsao TF; Chao YH
Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
[No Abstract] [Full Text] [Related]
10. Bullous variant of acral erythema in a child after high-dose methotrexate.
Zils K; Wilhelm M; Reeh T; Bielack S
Pediatr Hematol Oncol; 2012 May; 29(4):378-9. PubMed ID: 22568802
[No Abstract] [Full Text] [Related]
11. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
Womer RB
Pediatr Blood Cancer; 2010 Dec; 55(7):1250-1. PubMed ID: 20981687
[No Abstract] [Full Text] [Related]
12. Transient encephalopathy following high-dose methotrexate.
Lee AC; Li CH; Wong YC
Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
[No Abstract] [Full Text] [Related]
13. Bullous acral erythema secondary to high-dose methotrexate.
Morrell DS; Challgren E; Eapen M; Esterly NB
J Pediatr Hematol Oncol; 2002; 24(3):240. PubMed ID: 11990316
[No Abstract] [Full Text] [Related]
14. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
[No Abstract] [Full Text] [Related]
15. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
Mahadeo KM; Santizo R; Baker L; Curry JO; Gorlick R; Levy AS
Pediatr Blood Cancer; 2010 Dec; 55(7):1296-9. PubMed ID: 20949591
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate in adult oncology patients: a case-control study assessing the risk association between drug interactions and methotrexate toxicity.
Chan AJ; Rajakumar I
J Oncol Pharm Pract; 2014 Apr; 20(2):93-9. PubMed ID: 23698198
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate-induced bullous variant of acral erythema.
Hellier I; Bessis D; Sotto A; Margueritte G; Guilhou JJ
Arch Dermatol; 1996 May; 132(5):590-1. PubMed ID: 8624164
[No Abstract] [Full Text] [Related]
18. [Necrotizing myelopathy after intrathecal methotrexate].
Sanhes L; Delmer A; Zittoun R
Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
[No Abstract] [Full Text] [Related]
19. Methotrexate nephrotoxicity: Novel treatment, new approach.
Iqbal S; Armaghani A; Aiyer R; Kazory A
J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
[TBL] [Abstract][Full Text] [Related]
20. Renal dysfunction during and after high-dose methotrexate.
Green MR; Chamberlain MC
Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
